This compound is primarily utilized in pharmaceutical research and development, particularly in the synthesis of chiral intermediates for drug candidates. Its structure, featuring a bromophenyl group and an ester moiety, makes it valuable for constructing complex molecules, especially in the production of active pharmaceutical ingredients (APIs) targeting neurological and psychiatric disorders. Additionally, it serves as a building block in organic synthesis for creating compounds with potential therapeutic applications, such as enzyme inhibitors or receptor modulators. Its chiral nature is also exploited in asymmetric synthesis to produce enantiomerically pure substances.